Literature DB >> 9097328

Prevalence of general binocular dysfunctions in a population of university students.

E Porcar1, A Martinez-Palomera.   

Abstract

PURPOSE: Although some authors report that the prevalence of general binocular dysfunctions (nonstrabismic) for nonpresbyopes in the clinical population is greater than any condition except refractive error, limited research is available to support this statement. This clinical study determined the presence and clinical implications of these conditions in a population of university students with heavy near visual demands.
METHODS: From a group of second year students who were given a thorough eye examination, 65 students were selected. The criteria for selection were the absence of significant uncorrected refractive error, healthy eyes, and no strabismus or amblyopia.
RESULTS: 32.3% of the subjects showed general binocular dysfunctions. In 10.8% of the cases, accommodative excess was present. 7.7% had convergence insufficiency with accommodative excess. 6.2% showed accommodative insufficiency. 3.1% had basic exophoria. Convergence excess with accommodative insufficiency, basic esophoria, and fusional vergence dysfunction all showed the same prevalence of 1.5%.
CONCLUSIONS: Accommodative and nonstrabismic binocular vision problems are prevalent in this population. Accommodative excess is the most common condition. Because these dysfunctions may have a negative effect on performance, appropriate vision evaluation for this population is important.

Entities:  

Mesh:

Year:  1997        PMID: 9097328     DOI: 10.1097/00006324-199702000-00023

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  45 in total

1.  The effectiveness of disc synoptoscope on patients with abnormal binocular vision: a prospective cohort study.

Authors:  Jianglan Wang; Xin Ma; Ye Wu; Meng Liao; Longqian Liu
Journal:  Int Ophthalmol       Date:  2016-10-21       Impact factor: 2.031

2.  [Nintendo 3DS: technology, physiology and possible risks for children's eyes].

Authors:  A Pallas; C H Meyer; D Mojon
Journal:  Ophthalmologe       Date:  2013-03       Impact factor: 1.059

3.  Vision therapy in adults with convergence insufficiency: clinical and functional magnetic resonance imaging measures.

Authors:  Tara L Alvarez; Vincent R Vicci; Yelda Alkan; Eun H Kim; Suril Gohel; Anna M Barrett; Nancy Chiaravalloti; Bharat B Biswal
Journal:  Optom Vis Sci       Date:  2010-12       Impact factor: 1.973

4.  The incidence and clinical characteristics of adult-onset convergence insufficiency.

Authors:  Rafif Ghadban; Jennifer M Martinez; Nancy N Diehl; Brian G Mohney
Journal:  Ophthalmology       Date:  2015-01-24       Impact factor: 12.079

Review 5.  Non-surgical interventions for convergence insufficiency.

Authors:  Mitchell Scheiman; Jane Gwiazda; Tianjing Li
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

6.  Contact lenses vs spectacles in myopes: is there any difference in accommodative and binocular function?

Authors:  Raimundo Jiménez; Loreto Martínez-Almeida; Carlos Salas; Carolina Ortíz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-11-23       Impact factor: 3.117

7.  Randomized clinical trial of treatments for symptomatic convergence insufficiency in children.

Authors: 
Journal:  Arch Ophthalmol       Date:  2008-10

8.  Ophthalmologic findings in patients with non-surgically treated blowout fractures.

Authors:  Tony Pansell; Babak Alinasab; Anders Westermark; Mats Beckman; Saber Abdi
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2012-03

9.  Objective Assessment of Vergence after Treatment of Concussion-Related CI: A Pilot Study.

Authors:  Mitchell M Scheiman; Henry Talasan; G Lynn Mitchell; Tara L Alvarez
Journal:  Optom Vis Sci       Date:  2017-01       Impact factor: 1.973

10.  Symptoms in children with convergence insufficiency: before and after treatment.

Authors:  Carmen Barnhardt; Susan A Cotter; G Lynn Mitchell; Mitchell Scheiman; Marjean T Kulp
Journal:  Optom Vis Sci       Date:  2012-10       Impact factor: 1.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.